Pink eye, also known as conjunctivitis, is a common and highly contagious eye infection characterized by inflammation of the conjunctiva – the thin, clear tissue that lines the inside of the eyelid and covers the whites of the eyes. This condition earns its name due to the telltale symptom it presents: reddish or pink discoloration in one or both eyes. Pink eye can be caused by several factors including bacterial or viral infections, allergies, irritants like smoke or chemicals, and even certain sexually transmitted diseases. Regardless of its origins, pink eye typically manifests with uncomfortable symptoms such as itching, burning sensations, excessive tearing, or discharge which may lead to crusting around the eyes. While proper hygiene practices such as handwashing and avoiding touching your face can help prevent this ailment from spreading further among individuals in close proximity – particularly in places like schools or offices where transmission is swift – timely medical intervention remains crucial to alleviate discomfort and prevent prolonged recuperation periods associated with this common ocular affliction.
1.
Colon cancer and exercise: Can physical activity reprogram genes?
2.
For relapsed or resistant DLBCL, odronextamab produced positive results.
3.
Improved end-of-life conversations for cancer patients are identified by a new study.
4.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
5.
Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.
1.
Treating Methemoglobinemia: What You Need to Know Now!
2.
Is AI The New Radiologist For Breast MRI?
3.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
4.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
5.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation